Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.6632 per EA under NDC 00904690104. Its NADAC has been published 324 times since May 15, 2019.
Strength
100 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904690104
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA079179On Market Since
8/5/2016
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 324 times since May 15, 2019, and over the history we have for it it has declined 86.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6632 per EA |
|---|---|
| All-time high | $4.9463 (Feb 12, 2020) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.6632 |
| Median price | $0.8251 |
| Average price | $1.7129 |
| Largest weekly change | -74.1% (Jun 22, 2022) |
| Weeks tracked | 324 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Major Pharmaceuticals, is $0.6632 per EA (NDC 00904690104), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 86.6%. It has been tracked across 324 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since May 15, 2019, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $4.9463 (Feb 12, 2020), with a median of $0.8251 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 100 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 00904690104) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification